Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
634studies shown
Showing 445-456 of 634
Drug study icon
CompletedNCT05004896

Ketamine for Treatment-Resistant Bipolarity

This study is completed. It focuses on bipolarity and currently lists study information in Canada.

In Canada
Bipolarity, DepressionOtherFrom 21 Years to 65 Years
Countries
Canada
Sponsor
Joshua Rosenblat
Condition
Bipolarity, Depression
Drug study icon
SuspendedNCT03674671

Ketamine Versus Electroconvulsive Therapy in Depression

This study has public registry information. It focuses on depression and currently lists study information in Canada.

In Canada
Depression, BipolarityOtherFrom 18 Years to 70 Years
Countries
Canada
Sponsor
University of Ottawa
Condition
Depression, Bipolarity
Drug study icon
WithdrawnNCT01416220

Lithium Versus Paroxetine in Major Depression

This study has public registry information. It focuses on depression and currently lists study information in Canada.

In Canada
DepressionOtherOver 18 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.